Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Human Tetanus Immunoglobulin Market by Type (Injection, Freeze-dried Injection), By Application (Adults, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Human Tetanus Immunoglobulin Market by Type (Injection, Freeze-dried Injection), By Application (Adults, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130331 3300 Pharma & Healthcare 377 244 Pages 5 (34)

Market Overview:

The global human tetanus immunoglobulin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of tetanus, rising demand for human tetanus immunoglobulin in developing countries, and technological advancements in the field of human tetanus immunoglobulin production. However, factors such as high cost of treatment and lack of awareness about preventive measures against tetanus are restraining the growth of this market. Based on type, the global human tetanus immunoglobulin market can be segmented into injection and freeze-dried injection. Injection is further sub-segmented into lyophilized powder and reconstituted solution. Freeze-dried injection is further sub-segmented into dry powder form and frozen form.

Global Human Tetanus Immunoglobulin Industry Outlook

Product Definition:

Human Tetanus Immunoglobulin is a preparation of pooled human plasma containing antibodies to the tetanus toxin.


Injection is a medical procedure used to deliver medication into the body. Medication can be delivered intravenously, orally or subcutaneously. Injection is also known as inoculation, intradermal injection or skin vaccination and works by allowing active substances to enter the bloodstream through the outer layer of the skin.

The most common form of injections are vaccines for tetanus, diphtheria andpertussis (DPP3 inhibitor).

Freeze-dried Injection:

Freeze-dried injection (FDIn) is a drug delivery system that involves the use of lyophilized (freeze-dried) immunoglobulin in the form of an injectable. It is used to treat human tetanus, also known as byLock disease or byHorner's syndrome. The treatment for human tetanus consists of two injections every four to six weeks.

Application Insights:

Based on the application, the global human tetanus immunoglobulin market is segmented into adults and children. The adult segment held a larger share in 2017 as compared to the child segment. This is due to higher incidence of Tetanus infection among adults as compared to children. According to WHO, every year around 50 million people get infected with Tetanus worldwide and around 150,000 people die due to this condition. Moreover, according these statistics published by WHO in 2018 regarding Tetanus vaccination coverage across various regions globally; it was observed that more than 80% of population were vaccinated against this condition globally but less than 60% of population were vaccinated in some under-vaccinated regions such as South America and Africa which increases chances of getting infected subsequently leading towards higher demand for immunoglobulin therapy for treatment purposes driving the market growth during this period.

Regional Analysis:

North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high demand for immunoglobulin based products is expected to drive the regional market over the forecast period. In addition, increasing incidence oflockjaw and rising awareness about immunization programs are anticipated to propel product sales in this region.

Asia Pacific is expected to witness lucrative growth during the forecast period owing to growing medical tourism industry and improving healthcare infrastructure in emerging countries such as India, China, Thailand, Malaysia & Singapore. In addition, rising prevalence of neonatal jaundice and increasing incidence tetanus cases due lock jaw are also contributing towards regional growth.

Growth Factors:

  • Increasing incidence of tetanus across the globe
  • Growing demand for human tetanus immunoglobulin in developing countries
  • Rising awareness about the benefits of human tetanus immunoglobulin therapy
  • Technological advancements in the field of human tetanus immunoglobulin production
  • increasing number of research and development activities for novel therapeutics

Scope Of The Report

Report Attributes

Report Details

Report Title

Human Tetanus Immunoglobulin Market Research Report

By Type

Injection, Freeze-dried Injection

By Application

Adults, Children

By Companies

Baxalta, CSL, Octapharma, Grifols, LFB, Biotest, Kedrion, Hualan Biological Engineering

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Human Tetanus Immunoglobulin Market Report Segments:

The global Human Tetanus Immunoglobulin market is segmented on the basis of:


Injection, Freeze-dried Injection

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Adults, Children

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Baxalta
  2. CSL
  3. Octapharma
  4. Grifols
  5. LFB
  6. Biotest
  7. Kedrion
  8. Hualan Biological Engineering

Global Human Tetanus Immunoglobulin Market Overview

Highlights of The Human Tetanus Immunoglobulin Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Injection
    2. Freeze-dried Injection
  1. By Application:

    1. Adults
    2. Children
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Tetanus Immunoglobulin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Human Tetanus Immunoglobulin Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Human tetanus immunoglobulin is a protein that helps the body fight against tetanus. Tetanus is a serious infection caused by the bacterium Clostridium tetani. The disease can cause severe muscle spasms and even death if not treated quickly. Human tetanus immunoglobulin helps the body build immunity to this infection, so it can better fight off future attacks.

Some of the major players in the human tetanus immunoglobulin market are Baxalta, CSL, Octapharma, Grifols, LFB, Biotest, Kedrion, Hualan Biological Engineering.

The human tetanus immunoglobulin market is expected to register a CAGR of 5.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Human Tetanus Immunoglobulin Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Human Tetanus Immunoglobulin Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Human Tetanus Immunoglobulin Market - Supply Chain
   4.5. Global Human Tetanus Immunoglobulin Market Forecast
      4.5.1. Human Tetanus Immunoglobulin Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Human Tetanus Immunoglobulin Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Human Tetanus Immunoglobulin Market Absolute $ Opportunity

5. Global Human Tetanus Immunoglobulin Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Human Tetanus Immunoglobulin Market Size and Volume Forecast by Type
      5.3.1. Injection
      5.3.2. Freeze-dried Injection
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Human Tetanus Immunoglobulin Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Human Tetanus Immunoglobulin Market Size and Volume Forecast by Application
      6.3.1. Adults
      6.3.2. Children
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Human Tetanus Immunoglobulin Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Human Tetanus Immunoglobulin Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Human Tetanus Immunoglobulin Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Human Tetanus Immunoglobulin Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Human Tetanus Immunoglobulin Demand Share Forecast, 2019-2029

9. North America Human Tetanus Immunoglobulin Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Human Tetanus Immunoglobulin Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Human Tetanus Immunoglobulin Market Size and Volume Forecast by Application
      9.4.1. Adults
      9.4.2. Children
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Human Tetanus Immunoglobulin Market Size and Volume Forecast by Type
      9.7.1. Injection
      9.7.2. Freeze-dried Injection
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Human Tetanus Immunoglobulin Demand Share Forecast, 2019-2029

10. Latin America Human Tetanus Immunoglobulin Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Human Tetanus Immunoglobulin Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Human Tetanus Immunoglobulin Market Size and Volume Forecast by Application
      10.4.1. Adults
      10.4.2. Children
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Human Tetanus Immunoglobulin Market Size and Volume Forecast by Type
      10.7.1. Injection
      10.7.2. Freeze-dried Injection
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Human Tetanus Immunoglobulin Demand Share Forecast, 2019-2029

11. Europe Human Tetanus Immunoglobulin Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Human Tetanus Immunoglobulin Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Human Tetanus Immunoglobulin Market Size and Volume Forecast by Application
      11.4.1. Adults
      11.4.2. Children
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Human Tetanus Immunoglobulin Market Size and Volume Forecast by Type
      11.7.1. Injection
      11.7.2. Freeze-dried Injection
   11.8. Basis Point Share (BPS) Analysis by Type
   11.. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Human Tetanus Immunoglobulin Demand Share, 2019-2029

12. Asia Pacific Human Tetanus Immunoglobulin Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Human Tetanus Immunoglobulin Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Human Tetanus Immunoglobulin Market Size and Volume Forecast by Application
      12.4.1. Adults
      12.4.2. Children
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Human Tetanus Immunoglobulin Market Size and Volume Forecast by Type
      12.7.1. Injection
      12.7.2. Freeze-dried Injection
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Human Tetanus Immunoglobulin Demand Share, 2019-2029

13. Middle East & Africa Human Tetanus Immunoglobulin Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Human Tetanus Immunoglobulin Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Human Tetanus Immunoglobulin Market Size and Volume Forecast by Application
      13.4.1. Adults
      13.4.2. Children
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Human Tetanus Immunoglobulin Market Size and Volume Forecast by Type
      13.7.1. Injection
      13.7.2. Freeze-dried Injection
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Human Tetanus Immunoglobulin Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Human Tetanus Immunoglobulin Market: Market Share Analysis
   14.2. Human Tetanus Immunoglobulin Distributors and Customers
   14.3. Human Tetanus Immunoglobulin Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Baxalta Overview Financials Developments Strategic Outlook
      14.4.2. CSL Overview Financials Developments Strategic Outlook
      14.4.3. Octapharma Overview Financials Developments Strategic Outlook
      14.4.4. Grifols Overview Financials Developments Strategic Outlook
      14.4.5. LFB Overview Financials Developments Strategic Outlook
      14.4.6. Biotest Overview Financials Developments Strategic Outlook
      14.4.7. Kedrion Overview Financials Developments Strategic Outlook
      14.4.8. Hualan Biological Engineering Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us